Researchers have discovered a new molecular mechanism involved in premature atherosclerosis in mice with Hutchinson-Gilford progeria syndrome. The study identifies tauroursodeoxycholic acid as a potential therapeutic target that slows the progression of atherosclerosis and extends lifespan in progeroid mice.
Researchers at CNIC identified a very early marker of cardiac damage in patients undergoing anthracycline therapy, allowing for early diagnosis and potential prevention of irreversible damage. The discovery has implications for patient prognosis and may lead to new therapies based on mitochondrial transplantation.
A study by researchers at the CNIC reveals a new mechanism in intestinal bacteria regulation that prevents inflammation and promotes mutual benefit. The findings suggest that certain bacteria, such as Lactobacillus, strengthen the intestinal barrier through interaction with receptor Mincle.
Researchers at CNIC discovered a daily cycle that regulates neutrophil activation, protecting against infection but potentially causing damage to the cardiovascular system. The study suggests that manipulating this clock could lead to new treatments for patients at risk of cardiovascular events or infections.
The study found that participants who slept less than six hours were 27% more likely to have atherosclerosis compared to those who slept seven to eight hours. Poor quality sleep also increased the risk of atherosclerosis, with participants waking during the night or experiencing frequent movements during sleep being at higher risk.
Researchers have found that CD69 expression level inversely predicts subclinical atherosclerosis development. The study suggests that the molecule may play a role in controlling inflammation and preventing atherosclerosis.
Researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) have discovered a new mechanism that controls tissue infiltration by neutrophils, which are tasked with eliminating the source of infection or inflammation. This regulation prevents excessive tissue injury and is essential to understanding immune system balance.
A new study by CNIC researchers reveals that immune cells like neutrophils help maintain normal function of healthy tissues, performing roles unrelated to immunity. The findings suggest that the immune system is essential for day-to-day health, with potential benefits in some tissues and risks in others.
Researchers have identified P38 alpha as a crucial protein in activating brown fat cells to burn excess fat and eliminate the risk of obesity and related diseases. The study found that mice genetically modified to lack P38 alpha were protected against obesity, diabetes, and fatty liver disease.
Researchers found that mitochondrial DNA in exosomes triggers an antiviral genetic program, protecting against viral infection. Exosomes produced by T lymphocytes are taken up by dendritic cells via intercellular contacts and trigger alterations in gene expression.
The CNIC is leading a five-year Leducq Network project investigating genetic and environmental factors that promote clonal hematopoiesis and its link to cardiovascular disease. The project aims to understand the impact of clones on cardiovascular health and explore ways to modify their effects.
A CNIC-coordinated project will investigate the oxidative phosphorylation system (OXPHOS) and its structural heterogeneity, with potential implications for metabolic plasticity. Researchers from various countries and specialties will collaborate to develop new methods and gain a deeper understanding of this fundamental biological process.
Researchers have identified a new therapeutic target, OMA1, which protects cardiomyocytes from death and deterioration in heart function when the heart is under stress. Inhibition of OMA1 prevents heart failure in models of chronic tachycardia, hypertension, and myocardial ischemia with cardiac hypertrophy.
Researchers have generated the first mouse model of atherosclerosis accelerated by progerin, a protein causing Hutchinson-Gilford syndrome. The study identifies vascular smooth muscle cells as a key target for treating premature atherosclerosis in progeria.
Researchers at CNIC identified a function of the protease MT4-MMP, which increases surveillance activity of blood-patrolling monocytes. This blockade could potentiate treatments for infection or prevent metastasis, but its effects on later stages need analysis.
A study by CNIC scientists discovered that cardiomyocytes from the innermost heart regions can contribute to the regeneration of the external heart wall in zebrafish. This finding reveals a new way to rebuild a damaged heart and has implications for human heart regeneration.
Scientists identified a calcineurin variant CnAβ1 that reduces cardiac hypertrophy and improves heart function by preserving mitochondrial ATP production. This study may lead to new treatment strategies for conditions like aortic stenosis.
Researchers have identified a crucial mechanism in the regulation of titin protein, a key player in skeletal muscle and heart function. The study found that disulfide bonds play a significant role in determining titin's elastic properties, and their formation can cause major changes in the protein's elasticity.
A new study by CNIC researchers found that LDL-C is the main predictor of atherosclerotic plaques in individuals with no risk factors, such as hypertension or smoking. The study suggests that reducing LDL-C levels can help prevent the appearance of atherosclerosis.
A new study found that the Fuster-BEWAT score accurately predicts cardiovascular risk in healthy individuals, even without blood analysis. The score uses five health indicators: blood pressure, physical activity, BMI, fruit and vegetable intake, and smoking status.
A study published in Nature Communications identifies MKK6 as a key protein controlling white-to-brown fat conversion. This process enables lipids to be burned for heat instead of stored, potentially reducing obesity. Mice lacking MKK6 exhibit reduced body weight and protection against obesity.
Skipping breakfast increases the risk of atherosclerosis by up to 2.5 times, according to Spanish research. A high-energy breakfast reduces this risk, suggesting that eating habits play a crucial role in cardiovascular health.
A novel image analysis tool allowed researchers to observe which cells become 'losers' in cell competition and die, while others survive with higher Myc levels. This discovery reveals the importance of Myc levels in maintaining pluripotency during mammalian embryonic development.
Researchers at CNIC and FJD have demonstrated a bimodal postinfarction inflammatory reaction in human patients using advanced MRI technology. The study reveals two distinct edematous reactions occurring at different times after an infarction, with implications for clinical trials and future studies.
A study led by Dr. Susana Minguet identified the protein Caveolin-1 as a key regulator of B cell organization and signaling. The team found that Caveolin-1 deficiency leads to autoimmune disease in animal models, highlighting a new strategy for treating autoimmunity.
Researchers at CNIC have developed new methods to induce multispectral genetic mosaics in vertebrate models, allowing precise study of gene behavior. The technology enables simultaneous analysis of multiple genes in different cell populations, providing insights into gene interaction networks and regulatory hierarchies.
Researchers found that generating an optimal immune response against cancer requires the cooperation of two types of memory T cells: those that circulate in the blood and those that reside in tissues. This discovery has the potential to improve current cancer immunotherapy strategies, especially in preventing metastasis.
Researchers at CNIC reveal CTCF's crucial role in antibody generation and germinal center formation, shedding light on the immune response mechanisms. The study highlights the importance of CTCF for maintaining proper immune function and has implications for vaccine research.
Phagocytosis not only eliminates useless cells, but also 'educates' macrophages, the immune cells that carry it out. This process helps maintain tissues in a clean and healthy state. Researchers identified specific molecular toolkits for eliminating unwanted cells in each tissue.
Researchers at CNIC identified metoprolol's mechanism of action, which protects the heart from inflammation caused by neutrophils. The study opens up new applications for the cheap and safe drug, published in Nature Communications.
The 4DHeart project aims to bridge the gap between academia and industry, providing training for 6 predoctoral researchers in Europe. Students will be jointly supervised by academics and industry experts, gaining experience in research, innovation, and science communication.
Researchers at CNIC discovered that miR-28 regulates the terminal differentiation of B lymphocytes, blocking the growth of B cell lymphomas. This finding highlights the potential of synthetic miR-28 analogs to inhibit tumor growth in Burkitt lymphoma and diffuse large cell lymphoma.
Scientists have discovered that hypoxia-inducible transcription factors (HIFs) establish metabolic boundaries between cardiomyocytes to regulate maturation and contraction of the muscle. This pathway challenges previous models on heart metabolism, playing a critical role in correct formation of ventricles.
A team of CNIC scientists has characterized a cell signal called ISGylation that impairs the secretion of exosomes, which are crucial for intercellular communication. The discovery sheds light on how this signal affects exosome formation and could lead to new biomedical applications.
Progeria, a rare genetic disease, is characterized by an elevated risk of arrhythmias and premature death due to anomalies in the transmission of electrical signals in the heart. The study reveals that mislocalization of connexin 43 reduces connectivity between cardiomyocytes, increasing the risk of arrhythmias.
Researchers at the CNIC have defined the molecular organization underlying energy production in living cells. The discovery sheds light on the regulation of metabolism and reveals a new understanding of the mitochondrial electron transport chain's structure and function.
Researchers at CNIC have identified a mechanism that allows the Leishmania parasite to evade the immune system by binding to receptor Mincle on dendritic cells. The study found that the parasite's Mincle ligand weakens immune response, allowing it to replicate and be transmitted.
The MINERVA study found a significant association between higher medication adherence rates and improved patient outcomes, including reduced major adverse cardiovascular events (MACE) and healthcare costs. Fully adherent patients had a lower risk of MACE compared to partially and non-adherent populations.
Scientists have uncovered how the combination of nuclear and mitochondrial genomes triggers a cellular adaptation that determines aging. The study provides valuable information on using mitochondrial donation technology to prevent disease-causing mutations.
Researchers discovered that CD69 plays a key role in the development of psoriasis by regulating amino acid uptake and activation of inflammatory pathways. The study suggests that CD69 could serve as a future therapeutic target for treating this chronic inflammatory skin disease.
Scientists at CNIC discover how immune cells adapt to live bacteria through mitochondrial metabolism changes. The study found that detection of live bacteria triggers a change in the mitochondrial electron transport chain, enabling macrophages to redirect metabolic routes for efficient energy production.
Researchers at CNIC have discovered a crucial mechanism underlying the contractile structures in both hearts and skeletal muscles. The study reveals how Chd4/NuRD acts as a molecular key to shut down one muscle program in another, leading to hybrid striated muscles that can cause severe myocardiopathies and polymyositis-type myopathies.
CNIC researchers have identified a new target for the treatment of fatty liver disease, p38 gamma and p38 delta proteins. Inhibition of these proteins with specific inhibitors has shown potential as a treatment for fatty liver disease, potentially preventing inflammation, liver damage, and diabetes linked to obesity.
Researchers have identified two proteins controlling heart growth and adaptation to hypertension. The study reveals p38 gamma and p38 delta regulate left ventricle growth, enabling normal hearts to respond to external stimuli.
A study by CNIC researchers has identified a new mechanism through which blood stem cells regulate their proliferation and microenvironment. The protein ESL-1 controls the production of TGF-, a cytokine with antiproliferative properties, and is essential for maintaining HSCs in diseases like anemia.
A study published by CNIC researchers found a diet high in fatty acids can restore normal cell metabolism and prevent dilated cardiomyopathy. The research suggests that this approach may lead to future treatments for patients with heart disease.
A polypill combining three cardio-protective medicines has been approved in 15 European countries and is being commercialized across Europe. The innovative approach aims to reduce societal burden and improve patient treatment, with the focus on increasing adherence to prescribed medication.
A group-therapy intervention program achieves significant improvements in cardiovascular risk factors, including blood pressure, exercise, weight, diet, and tobacco smoking. The program also encourages participants to adopt healthy habits and increase physical activity.
Researchers at CNIC identified the molecular mechanism regulating transport of Rac1 between nucleus and cytoplasm. Sustained presence of Rac1 in nucleus promotes nuclear deformation to facilitate cell migration through confined spaces. The study provides potential targets for future therapies.
Researchers discovered that tamoxifen blocks symptoms and progression of myeloproliferative neoplasms by targeting hematopoietic stem cells, potentially leading to effective therapy for certain blood disorders.